Substance

ID:73481

Names and Identifiers
IUPAC name
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
IUPAC Traditional name
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
Synonyms
ErymaxErycEry-TabErythromycinEmgel
Registration numbers
CAS Number
Properties
Safety Information
Storage Condition
-20°C
Physical Property
Solubility
DMSO
Product Information
Salt Data
Free Base
Molecule Details
Research Area: Infection
Biological Activity:
Erythromycin is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people who have an allergy to penicillins. For respiratory tract infections, it has better coverage of atypical organisms, including mycoplasma and Legionellosis. [1] In a study of in-vitro and in-vivo susceptibility of Borrelia burgdorferito, erythromycin possessed low activity, having an ED50 of 122.2 (±51.9) mg/kg. [2] For erythromycin, an IC50 of 1.5 μg/ml was observed, indicating a fourfold lower sensitivity of the organisms to this compound. [3]
Molecular Spectra
No Data Available
Click here to submit data
References
•  http://en.wikipedia.org/wiki/Erythromycin